- Home
- ACIU vs AEHR Comparison
ACIU vs AEHR Comparison
Compare ACIU & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- AEHR
- Stock Information
- Founded
- ACIU 2003
- AEHR 1977
- Country
- ACIU Switzerland
- AEHR United States
- Employees
- ACIU N/A
- AEHR N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- AEHR Electrical Products
- Sector
- ACIU Health Care
- AEHR Industrials
- Exchange
- ACIU Nasdaq
- AEHR Nasdaq
- Market Cap
- ACIU 189.1M
- AEHR 214.5M
- IPO Year
- ACIU 2016
- AEHR 1997
- Fundamental
- Price
- ACIU $2.07
- AEHR $15.54
- Analyst Decision
- ACIU Strong Buy
- AEHR
- Analyst Count
- ACIU 1
- AEHR 0
- Target Price
- ACIU $12.00
- AEHR N/A
- AVG Volume (30 Days)
- ACIU 139.5K
- AEHR 1.3M
- Earning Date
- ACIU 08-05-2025
- AEHR 07-08-2025
- Dividend Yield
- ACIU N/A
- AEHR N/A
- EPS Growth
- ACIU N/A
- AEHR 50.16
- EPS
- ACIU N/A
- AEHR 0.78
- Revenue
- ACIU $32,014,254.00
- AEHR $61,479,000.00
- Revenue This Year
- ACIU N/A
- AEHR N/A
- Revenue Next Year
- ACIU $533.21
- AEHR $22.53
- P/E Ratio
- ACIU N/A
- AEHR $20.04
- Revenue Growth
- ACIU 91.20
- AEHR N/A
- 52 Week Low
- ACIU $1.43
- AEHR $6.27
- 52 Week High
- ACIU $4.26
- AEHR $21.44
- Technical
- Relative Strength Index (RSI)
- ACIU 56.20
- AEHR 77.45
- Support Level
- ACIU $1.65
- AEHR $12.45
- Resistance Level
- ACIU $2.17
- AEHR $12.15
- Average True Range (ATR)
- ACIU 0.17
- AEHR 0.87
- MACD
- ACIU -0.01
- AEHR 0.32
- Stochastic Oscillator
- ACIU 70.37
- AEHR 94.58
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About AEHR Aehr Test Systems
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.